Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
51.1M
-
Number of holders
-
173
-
Total 13F shares, excl. options
-
26M
-
Shares change
-
+3.65M
-
Total reported value, excl. options
-
$1.87B
-
Value change
-
+$332M
-
Put/Call ratio
-
0.67
-
Number of buys
-
127
-
Number of sells
-
-54
-
Price
-
$71.75
Significant Holders of REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) as of Q2 2018
209 filings reported holding RGNX - REGENXBIO Inc. - Common Stock, par value $0.0001 per share as of Q2 2018.
REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) has 173 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26M shares
of 51.1M outstanding shares and own 50.9% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.22M shares), RTW INVESTMENTS, LP (2.08M shares), VANGUARD GROUP INC (1.86M shares), FMR LLC (1.62M shares), Redmile Group, LLC (1.56M shares), STATE STREET CORP (1.33M shares), JPMORGAN CHASE & CO (1.08M shares), WS MANAGEMENT LLLP (1.04M shares), PERCEPTIVE ADVISORS LLC (867K shares), and FRANKLIN RESOURCES INC (743K shares).
This table shows the top 173 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.